Vudalimab
Nonsquamous Non-small Cell Lung Cancer
Xencor, Inc.Phase 1/2
—
Rating in progress
Vudalimab in Nonsquamous Non-small Cell Lung Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active